1.
|
9 p, 147.5 KB |
International Consensus Guidance for Management of Myasthenia Gravis
/
Narayanaswami, Pushpa (Beth Israel Deaconess Medical Center/Harvard Medical School) ;
Sanders, Donald B. (Boston, MA; Department of Neurology) ;
Wolfe, Gil (Duke University Medical Center, Durham, NC; Department of Neurology) ;
Benatar, Michael (Univ. at Buffalo Jacobs School of Medicine and Biomedical Sciences, State University of New York, Buffalo, NY; Department of Neurology) ;
Cea, Gabriel (University of Miami, Miller School of Medicine. Miami, FL) ;
Evoli, Amelia (Dipartimento di Neuroscienze, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy) ;
Gilhus, Nils Erik (Department of Clinical Medicine, University of Bergen, Norway) ;
Illa, Isabel (Institut d'Investigació Biomèdica Sant Pau) ;
Kuntz, Nancy L. (Departments of Pediatrics and Neurology, Northwestern Feinberg School of Medicine, Chicago, IL) ;
Massey, Janice (Boston, MA; Department of Neurology) ;
Melms, Arthur (Neurology, University of Tübingen Medical Centre, Tübingen, Germany) ;
Murai, Hiroyuki (Department of Neurology, International University of Health and Welfare, Narita, Japan) ;
Nicolle, Michael (Department of Clinical Neurological Sciences, Western University, London, ON, Canada) ;
Palace, Jacqueline (John Radcliffe Hospital (Oxford, Regne Unit)) ;
Richman, David (department of Neurology, University of California, Davis, Davis, CA) ;
Verschuuren, Jan (Department of Neurology, Leiden University Medical Centre, Leiden, the Netherlands) ;
Universitat Autònoma de Barcelona
To update the 2016 formal consensus-based guidance for the management of myasthenia gravis (MG) based on the latest evidence in the literature. In October 2013, the Myasthenia Gravis Foundation of America appointed a Task Force to develop treatment guidance for MG, and a panel of 15 international experts was convened. [...]
2021 - 10.1212/WNL.0000000000011124
Neurology, Vol. 96 (january 2021) , p. 114-122
|
|
2.
|
7 p, 189.2 KB |
International consensus guidance for management of myasthenia gravis
/
Sanders, Donald B. (Duke University Medical Center) ;
Wolfe, Gil I. (Duke University Medical Center) ;
Benatar, Michael (University at Buffalo School of Medicine and Biomedical Sciences, State University of New York; Department of Neurology) ;
Evoli, Amelia (University of Miami, Miller School of Medicine (FL, Estats Units d'Amèrica). Department of Neurology) ;
Gilhus, Nils E. (Catholic University (Roma, Itàlia). Department of Clinical Medicine) ;
Illa, Isabel (Institut d'Investigació Biomèdica Sant Pau) ;
Massey, Janice M. (Duke University Medical Center) ;
Kuntz, Nancy (Duke University Medical Center) ;
Melms, Arthur (Northwestern Feinberg School of Medicine (Chicago, Estats Units d'Amèrica)) ;
Murai, Hiroyuki (University of Tübingen (Alemanya). Department of Neurological Therapeutics) ;
Nicolle, Michael (Kyushu University (Fukuoka, Japó). Department of Clinical Neurological Sciences) ;
Palace, Jacqueline (Western University (London, Canadà). Department of Clinical Neurology) ;
Richman, David P. (John Radcliffe Hospital (Oxford, Regne Unit)) ;
Verschuuren, Jan (University of California (Davis, Estats Units d'Amèrica). Department of Neurology) ;
Narayanaswami, Pushpa (Leiden University Medical Centre) ;
Universitat Autònoma de Barcelona
To develop formal consensus-based guidance for the management of myasthenia gravis (MG). In October 2013, the Myasthenia Gravis Foundation of America appointed a Task Force to develop treatment guidance for MG, and a panel of 15 international experts was convened. [...]
2016 - 10.1212/WNL.0000000000002790
Neurology, Vol. 87 (july 2016) , p. 419-425
|
|